Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beersheba
Clinical trial register · Israel

Clinical Trials in Beersheba, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Israel and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2438 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2438
Studies in scope
all four open statuses
1243
Recruiting now
open to new participants
461
Lead sponsors
across recruiting studies
Top sites
Jerusalem 52 Haifa 49 Ramat Gan 43 Petah Tikva 40 Kfar Saba 39
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Eli Lilly and Company21 Merck Sharp & Dohme LLC19 AbbVie18 AstraZeneca13 Hoffmann-La Roche12 Clear sponsor filter
Site location
Jerusalem52 Haifa49 Ramat Gan43 Petah Tikva40 Kfar Saba39
All 21 locations
Target enrolment
to

Trials with a site in Beersheba

13 of 2438 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Israel
Start
Recruiting
AstraZeneca
Phase 3
1,100
Afula, Beersheba, Hadera, Haifa, Holon, Jerusalem, Kfar Saba, Nahariya
2025-12-29
Recruiting
AstraZeneca
Phase 3
700
Afula, Beersheba, Hadera, Haifa, Jerusalem, Kfar Saba, Nahariya, Petah Tikva
2025-08-06
Recruiting
AstraZeneca
Phase 3
830
Afula, Beersheba, Hadera, Haifa, Jerusalem, Ramat Gan, Tel Aviv
2025-04-10
Recruiting
AstraZeneca
Phase 3
11,300
Beersheba, Be’er Ya‘aqov, Haifa, Herzelia, Holon, Jerusalem, Petah Tikva, Ramat Gan
2025-03-14
Recruiting
AstraZeneca
Phase 3
3,850
Afula, Ashkelon, Beersheba, Be’er Ya‘aqov, Haifa, Holon, Jerusalem, Kfar Saba
2024-04-12
Recruiting
AstraZeneca
Phase 3
3,527
Afula, Ashkelon, Beersheba, Haifa, Holon, Jerusalem, Petah Tikva, Ramat Gan
2022-12-13
Active, closed
AstraZeneca
Phase 3
98
Beersheba, Jerusalem, Kfar Saba, Tel Aviv, Tel HaShomer
2021-09-12
Active, closed
AstraZeneca
Phase 3
315
Beersheba, Haifa, Jerusalem, Petah Tikva, Ramat Gan
2021-06-30
Active, closed
AstraZeneca
Phase 3
818
Afula, Beersheba, Haifa, Jerusalem, Kfar Saba, Petah Tikva, Ramat Gan
2020-04-16
Active, closed
AstraZeneca
Phase 3
140
Ashkelon, Beersheba, Jerusalem, Ramat Gan, Rehovot, Tel Aviv
2019-10-29
Active, closed
AstraZeneca
Phase 3
953
Beersheba, Jerusalem, Kfar Saba, Nahariya, Petah Tikva, Ramat Gan
2015-11-03
Active, closed
AstraZeneca
Phase 3
682
Beersheba, Haifa, Jerusalem, Kfar Saba, Petah Tikva, Ramat Gan, Tel Aviv
2015-10-21
Active, closed
AstraZeneca
Phase 3
510
Beersheba, Haifa, Kfar Saba, Petah Tikva, Tel Aviv, Tel HaShomer
2013-09-25
Rows per page Showing 1–13 of 13
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Israeli investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 October 2026. https://priyalifescience.com/clinical-trials-israel/city/beersheba

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Israel and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,438 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 13 of those studies with a site in Beersheba that also match the filters currently applied.

How many clinical trials are recruiting in Beersheba?

6 of the 13 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 7 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Beersheba), 13 studies
PhaseStudiesRecruitingShare
Phase 3136100%

Most active sponsors

Lead sponsors with the most studies (Beersheba)
Lead sponsorStudiesRecruiting
AstraZeneca136
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.